Funds withheld receivable: (Allowance for expected credit losses: 2026: $2; 2025: $2)

Name: King Pharmaceuticals Funds withheld receivable: (Allowance for expected credit losses: 2026: $2; 2025: $2) by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

King Pharmaceuticals·Business Segments·2 segments·Rolls up to Assets held in trust accounts, reinsurance agreements

Breakdown

Segment	Q3 '25	Q4 '25	Q1 '26
Legacy Reinsurance	$11.94M	$10.96M	$7.45M
Program Services	$0	$0	$0
Total	$11.94M	$10.96M	$7.45M

Segments

Legacy ReinsuranceView metric

Program ServicesView metric